NEW YORK (GenomeWeb News) — Beckman Coulter today said it will pay a dividend of 16 cents per share on May 25 to all shareholders of record on May 11.  
 
Also today, investment bank RBC Capital upgraded Beckman’s stock to ‘outperform’ after Beckman yesterday posted strong first-quarter revenue and profit gains.
  

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.